Sort
261,768 grants matching “gene therapy”
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,992,416Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Pyrimidine metabolism in the development of autoreactive B cells and SLE
$2,989,958Ziaur Rahman · Thomas Jefferson University · R01 · FY2025 · AI
Center for Genetic Studies of Drug Abuse in Outbred Rats
$2,989,274Abraham A Palmer · University Of California, San Diego · P50 · FY2022 · DA
Targets to Therapeutics in Pancreatic Cancer
$2,988,784Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2006 · CA
Development of Complement Modulating Therapeutics for AMD
$2,986,452Gregory S Hageman · University Of Utah · R24 · FY2010 · EY
Center for Genetic Studies of Drug Abuse in Outbred Rats
$2,985,563Abraham A Palmer · University Of California, San Diego · P50 · FY2020 · DA
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer
$2,985,202Jonine Lisa Bernstein · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Structural Cell Biology of DNA Repair Machines
$2,985,088John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2022 · CA
The Wake Forest Nonhuman Primate Radiation Survivor Cohort
$2,984,779J. Mark Cline · Wake Forest University Health Sciences · U01 · FY2024 · AI
NEW METHODS FOR CANCER DETECTION
$2,984,622Weill Medical College Of Cornell Univ · P01 · FY2004 · CA
Comprehensive Liquid Biomarkers to Personalize Therapy in Renal Cell Carcinoma
$2,984,495Rana Ramzi McKay · University Of California, San Diego · R01 · FY2025 · CA
JACKSON HEART STUDY
$2,981,813Herman Alfred Taylor · University Of Mississippi Med Ctr · N01 · FY2009 · HL
Lung Transplant Clinical Trial Network (LT-CTN)
$2,981,212Scott M Palmer · Duke University · U01 · FY2021 · AI
SOUTHWEST REGIONAL PRIMATE RESEARCH CENTER
$2,981,030Southwest Foundation For Biomedical Res · P51 · FY2000 · RR
The Wake Forest Nonhuman Primate Radiation Survivor Cohort
$2,980,829J. Mark Cline · Wake Forest University Health Sciences · U01 · FY2025 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$2,979,516Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of Complement Modulating Therapeutics for AMD
$2,979,061Gregory S Hageman · University Of Utah · R24 · FY2009 · EY
Targeting Cerebrovascular TGF Signaling in Alzheimer's Disease
$2,978,965Jian Luo · Palo Alto Veterans Instit For Research · RF1 · FY2018 · AG
Novel hematopoietic stem cell engineering and transplantation approaches for HIV cure
$2,978,475Paula M Cannon · University Of Southern California · U19 · FY2022 · HL
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,978,290Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System
$2,977,025Marcie A Glicksman · Enclear Therapies, Inc. · R44 · FY2025 · NS
Discovery and Development of Therapeutic Genes for CHF
$2,976,411H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2016 · HL
Lung Transplant Clinical Trial Network (LT-CTN)
$2,975,390Scott M Palmer · Duke University · U01 · FY2022 · AI
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$2,975,228Ali Naji · University Of Pennsylvania · U01 · FY2021 · AI
Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
$2,975,228Ali Naji · University Of Pennsylvania · U01 · FY2022 · AI